Source comparison
The GHRH-R vs GHS-R1a Distinction
Understanding the receptor difference is fundamental to understanding why these compounds are complementary rather than competitive. GHRH-R (tesamorelin's target): Located on pituitary somatotrophs. Activation triggers adenylyl cyclase, increases cAMP, phospho
This comparison does not assign a generated winner or score.
- Understanding the receptor difference is fundamental to understanding why these compounds are complementary rather than competitive.
- GHRH-R (tesamorelin's target): Located on pituitary somatotrophs. Activation triggers adenylyl cyclase, increases cAMP, phosphorylates PKA, and ultimately drives GH gene expression and release. GHRH is the hypothalamic signal that the pituitary is designed to receive as the primary "produce GH" command.
- GHS-R1a (ipamorelin's target): Located in the hypothalamus and pituitary. Activation through phospholipase C and calcium signaling amplifies GH release through a pathway independent of cAMP. The ghrelin receptor pathway was discovered later than the GHRH pathway and represents a second, distinct mechanism for physiological GH regulation.
- In normal physiology, both GHRH and ghrelin act simultaneously to produce maximal GH pulses — GHRH provides the foundation signal while ghrelin amplifies it. Tesamorelin and ipamorelin together replicate this dual-pathway activation.